SCHEMBL396766

SCHEMBL396766

C=C(C)C(=O)OCC[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.47
TSHR P16473 3/20 0.46
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.36
APEX1 P27695 1/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16425735 0.93 THRB (0.42) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL35807 0.89 TSHR (0.51) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL333002 0.88 TSHR (0.50) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL397519 0.88 TSHR (0.54) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL393193 0.86 TSHR (0.57) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL395576 0.86 TSHR (0.57) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL396934 0.85 THRB (0.47) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL9303996 0.85 THRB (0.47) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL9418354 0.85 TSHR (0.47) THRBTSHRALDH1A1POLBAPEX1
SCHEMBL11312944 0.85 TSHR (0.47) THRBTSHRALDH1A1POLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117784447-B High-efficient soft hydrophilic contact lens of moisturizing 四川兴泰普乐医疗科技有限公司 2024-05-10 CN claimed
JP-63216044-A None JP disclosed
CN-117784447-B High-efficient soft hydrophilic contact lens of moisturizing 四川兴泰普乐医疗科技有限公司 2024-05-10 CN disclosed
US-11427666-B2 Silicone-containing acrylic polymers for transdermal drug delivery compositions NOVEN PHARMACEUTICALS, INC. (US) 2022-08-30 US disclosed
US-20200277424-A1 SILICONE-CONTAINING ACRYLIC POLYMERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS NOVEN PHARMACEUTICALS, INC. (US) 2020-09-03 US disclosed
EP-3179989-B1 SILICONE-CONTAINING ACRYLIC POLYMERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS NOVEN PHARMA (US) 2019-06-12 EP disclosed
US-10004666-B2 Compositions for endodontic instruments DENTSPLY SIRONA INC. (US) 2018-06-26 US disclosed
EP-3179989-A1 SILICONE-CONTAINING ACRYLIC POLYMERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS Noven Pharmaceuticals, INC. (US) 2017-06-21 EP disclosed
US-20160235632-A1 COMPOSITIONS FOR ENDODONTIC PROCEDURES DENTSPLY SIRONA, Inc. (US) 2016-08-18 US disclosed
US-20160235632-A1 COMPOSITIONS FOR ENDODONTIC PROCEDURES DENTSPLY SIRONA, Inc. (US) 2016-08-18 US disclosed
US-8101789-B2 Method for the production of polymerizable silicones WACKER CHEMIE AG (DE) 2012-01-24 US disclosed
EP-2125833-B1 METHOD FOR THE PRODUCTION OF POLYMERISABLE SILICONES WACKER CHEMIE AG (DE) 2010-08-25 EP disclosed
EP-2125834-B1 METHOD FOR THE PRODUCTION OF POLYMERISABLE SILICONES WACKER CHEMIE AG (DE) 2010-08-25 EP disclosed
US-20100041909-A1 METHOD FOR THE PRODUCTION OF POLYMERIZABLE SILICONES WACKER CHEMIE AG (DE) 2010-02-18 US disclosed
US-20100029972-A1 METHOD FOR THE PRODUCTION OF POLYMERIZABLE SILICONES WACKER CHEMIE AG (DE) 2010-02-04 US disclosed
EP-0611783-B1 Copolymers of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives CIBA GEIGY AG (CH) 1998-04-01 EP disclosed
US-5376378-A Transdermal drug delivery CIBA-GEIGY CORP. (US) 1994-12-27 US disclosed
EP-0611783-A1 Copolymers of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives CIBA-GEIGY AG (CH) 1994-08-24 EP disclosed
US-5288827-A Drug selivery CIBA-GEIGY CORPORATION (US) 1994-02-22 US disclosed
JP-S63216044-A PATTERN FORMING MATERIAL NIPPON ZEON CO LTD 1988-09-08 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160235632-A1 COMPOSITIONS FOR ENDODONTIC PROCEDURES RNGTT, CDH1, GATAD2B THRB 3999/4885TSHR 4836/4885ALDH1A1 3128/4885
US-10004666-B2 Compositions for endodontic instruments XPO5, PEF1, ATP6V0C THRB 4700/4885TSHR 4828/4885ALDH1A1 4125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.